These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10351898)

  • 1. Drug targets cellular enzyme.
    AIDS Patient Care STDS; 1999 Apr; 13(4):247-8. PubMed ID: 10351898
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond hydroxyurea.
    Smart T
    GMHC Treat Issues; 1995 Sep; 9(9):5. PubMed ID: 11362909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
    Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCI plans attack on HIV resistance.
    Science; 1997 May; 276(5313):667. PubMed ID: 9157541
    [No Abstract]   [Full Text] [Related]  

  • 6. New ribonucleotide reductase inhibitors with antineoplastic activity.
    Elford HL; Wampler GL; van't Riet B
    Cancer Res; 1979 Mar; 39(3):844-51. PubMed ID: 427774
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA-protective activity of new ribonucleotide reductase inhibitors.
    Rauko P; Romanova D; Miadokova E; Macakova K; Novotny L; Elford HL; Szekeres T
    Anticancer Res; 1997; 17(5A):3437-40. PubMed ID: 9413183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
    Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
    Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantum-chemical studies on the mechanisms of inhibition of ribonucleotide reductase by aryl hydroxamic acids].
    Xu X; Luo YF; Cai WZ
    Yao Xue Xue Bao; 1993; 28(1):17-21. PubMed ID: 8328264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging HIV drug resistance in Africa.
    AIDS Read; 2000 Aug; 10(8):468. PubMed ID: 10967804
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.
    Parkin NT; Lie YS; Hellmann N; Markowitz M; Bonhoeffer S; Ho DD; Petropoulos CJ
    J Infect Dis; 1999 Sep; 180(3):865-70. PubMed ID: 10438382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and clinical research of HIV-1 resistance in three AIDS patients who had experienced multiple regimens.
    Lu JF; Li J; Li HP; Liu SY; Zhuang DM; Liu YJ; Bao ZY; Li L; Wu H; Li JY
    Chin Med J (Engl); 2009 Mar; 122(6):752-4. PubMed ID: 19323948
    [No Abstract]   [Full Text] [Related]  

  • 13. Current clinical treatments of AIDS.
    Murphy EM; Jimenez HR; Smith SM
    Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408
    [No Abstract]   [Full Text] [Related]  

  • 14. [AIDS: the myth of Sisyphus].
    Jaubert D
    Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
    Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
    Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justice and access to therapies for AIDS.
    Eckenwiler L
    AIDS Public Policy J; 1999; 14(1):20-5. PubMed ID: 10915283
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral drug resistance and HIV/AIDS in the developing world.
    Vella S
    J HIV Ther; 2002 Aug; 7(3):53-5. PubMed ID: 12442164
    [No Abstract]   [Full Text] [Related]  

  • 18. The new inhibitors of ribonucleotide reductase--comparison of some physico-chemical properties.
    Romanova D; Vachalkova A; Szekeres T; Elford HL; Novotny L
    J Pharm Biomed Anal; 1997 Apr; 15(7):951-6. PubMed ID: 9160261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rhetoric of inaction.
    Gonsalves G
    GMHC Treat Issues; 2002 Jun; 16(6):12. PubMed ID: 12141286
    [No Abstract]   [Full Text] [Related]  

  • 20. Reservoirs dog AIDS therapy.
    Smaglik P
    Nature; 2000 May; 405(6784):270-2. PubMed ID: 10830936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.